Shares have dipped 12% in 2025.
Related Posts
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Embattled genetic testing provider 23andMe said Tuesday that revenue declined from a year earlier, a day after the company announced a cost-cutting plan.
Stocks making the biggest moves midday: Apple, Alibaba, Palantir Technologies and more
These are the stocks posting the largest moves in midday trading.
Supreme Court rules for South Carolina over bid to defund Planned Parenthood
The dispute arose from a long-running effort by the state to block the reproductive health care group from receiving Medicaid funds.